Skip to main content
Log in

Burden of type 2 diabetes complications substantial in Sweden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Funding for the study was provided by Novo Nordisk A/S, Denmark, to the Swedish Institute for Health Economics, Lund, Sweden.

Reference

  • Andersson E, et al. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden. Diabetologia : 24 Sep 2020. Available from: URL: http://doi.org/10.1007/s00125-020-05277-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burden of type 2 diabetes complications substantial in Sweden. PharmacoEcon Outcomes News 863, 6 (2020). https://doi.org/10.1007/s40274-020-7160-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7160-3

Navigation